A newly identified colon cancer gene may drive the disease by making the environment in the vicinity of tumors more hospitable to them, researchers say. The gene, which appears to speed tumor growth ...
Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...
A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA ...
Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...
BGB-B2033, a bispecific antibody, targets 4-1BB and GPC3, showing potential in advanced hepatocellular carcinoma (HCC) ...
The Fast Company Impact Council is an invitation-only membership community of top leaders and experts who pay dues for access to peer learning, thought leadership, and more. BY Jurgi Camblong Cancer ...
Colorectal cancer is officially the leading cause of cancer-related death among younger men, according to a January report by the American Cancer Society. It is also the second leading cause for women ...
Sonali Bendre has opened up about her battle with cancer. The actress, who was diagnosed with stage four metastatic cancer in ...
Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...
Alcohol associated cancer deaths have doubled in the United States over the past three decades, disproportionately impacting men and people 55 and older, according to a new, yet to be published, study ...
Fitgurú on MSN
Scientist warns these everyday habits could quietly trigger cancer and reveals how to reverse the damage
A leading cancer researcher says stress, fast food, alcohol, and poor sleep are creating the perfect storm for disease, but a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for eganelisib (IPI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback